With new CPT reimbursement codes for cardiac computed tomography (CT) starting in January 2010, there will likely be renewed interest in CT this coming year.

November 18, 2009 - Advanced visualization tools are increasingly important to support radiologists as they diagnose complex MR, CT, SPECT cases. To meet the demands on radiologists to complete reads efficiently, accurately and provide these tools, a workstation should be built on highly scalable architecture and be accessible remotely.

November 18, 2009 โ€“ The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the reimbursement for positron emission tomography (PET) cardiac procedures in 2010.

November 18, 2009 โ€“ Utilizing newer cardiac computed tomography (CT) machines to find plaque and blockages in the coronary arteries led to better survival among those undergoing the test, according to a study presented Sunday at the American Heart Association Meeting in Orlando, Fla.


Our profession faces one of the most significant crises in its history,โ€ said Michael Graham, M.D., president of the Society of Nuclear Medicine (SNM), regarding the shortage of nuclear medicine radioisotopes.

November 17, 2009 โ€“ Scientists have created a one-step, point-of-care diagnostic test based on a silicon chip that uses a smaller blood sample, is significantly faster, portable and easier to use than current testing devices used to detect disease markers.

November 17, 2009 โ€“ A new genetic test to detect familial dilated cardiomyopathy (DCM), the FAMILION DCM Test, was introduced this week at the 2009 American Heart Association (AHA) meeting in Orlando, Fla.

November 17, 2009 โ€“ Following three reports of stretching and fractures during procedures, the ViperSheath Sheath Introducer was voluntarily recalled on November 2 by Cardiovascular Systems Inc. (CSI).


Intra-aortic balloon pumps (IABPs), introduced in the 1970s, have been considered the standard of care for short-term circulatory support for more than two decades. However, there has been a growing trend over the past few years toward percutaneous ventricular assist devices (VADs), which some cardiologists say have some big advantages over IABPs.

In recent years, the U.S. cardiac device market has focused on dynamics in the drug-eluting stent (DES) segment โ€“ including events ranging from the 2006 BASKET-LATE trial that caused a tremendous decline in DES usage to the 2008 launch of three new DES brands in the U.S. Focus in 2010 will shift somewhat, with a relatively steady DES market leaving room for other areas to heat up.
Subscribe to
ยฉ Copyright Wainscot Media. All Rights Reserved.
Subscribe Now